Generic drug makers benefit from US conditions
Mayne Pharma and Acrux are capitalising on the ongoing push for lower drug prices, especially in the US.
Mayne Pharma and Acrux are capitalising on the ongoing push for lower drug prices, especially in the US.
Something you might not know: we’re in the middle of World Antimicrobial Resistance Awareness Week. These three superbug-tackling ASX health firms are certainly aware.
Expert market analyst Steve Collette believes ASX stock Spartan Resources could have a golden near future.
The ASX dipped on Wednesday as energy stocks led losses. Global tensions weighed on markets but gold stocks rose… all ahead of Nvidia’s incoming earnings report.
Narryer Metals lifted on rare earth hits in WA’s Great Southern, where former Cassini Resources boss Richard Bevan is chasing his next win.
The ASX dips amid geopolitical tensions, Amcor falls on $13 billion acquisition, while Narryer Metals strikes high-grade scandium and rare earths.
Donald Trump’s appointment of Robert F Kennedy Junior as health czar means interesting times for US-focused ASX life sciences plays
Painchek is eyeing a US market of 1.7 million aged-care beds for its mobile-based pain detection tool.
The ASX kissed a record high on Tuesday, led by tech, energy and gold stocks, with gold rising above US$2600.
The ASX IPO market is picking up after a quiet 2024 with major listings ahead, including Symal, Fulcrum and Cuscal.
Metallurgical testing has proved that titanium minerals are present at the Rosewood prospect – a huge boost for Petratherm.
The ASX has risen on Tuesday, with energy stocks up and Petratherm hitting high-grade titanium in South Australia.
Pathology and radiology giant Sonic Healthcare is recovering from its post-pandemic malaise and says earnings should improve this year.
Record gold prices and corporate activity have shined a light on WA’s Laverton gold field, where these explorers are chasing new discoveries.
With FDA approval in the bag for its AI-based aortic stenosis diagnostic tool, Echo IQ is focused on commercialisation over the next few years.
The ASX is trading flat as US rate fears weigh. Meanwhile NAB has been hit by a lawsuit and new bank levy, and Alderan jumps on copper-drilling hit in the US.
With a market cap of just $6m, Silver hunter Sierra Nevada Gold may be the next cab off the rank in the ASX silver revival.
The ASX closing bell has rung, with the local bourse ending Monday on a positive note. Mining gains offset tech and bank losses, while uranium stocks soared.
A $13.5m tungsten deal, a cheap silver explorer and a uranium enrichment play are among the Aussie resources stocks posting gains on Monday.
Harvard University’s main teaching hospital will use Echo IQ’s AI-based Echosolv tool to detect aortic stenosis (heart valve disease). Tim Boreham reports.
Geothermal and nuclear energy have emerged as the top choice to power Big Tech’s data centres. These ASX companies are on the case.
Pilbara Minerals tops the ASX short-selling list again, but buying heavily shorted stocks could trigger a short squeeze.
Australia is poised to become a health and medical products manufacturing powerhouse, according to government and industry leaders.
In this week’s Ethical Investor Eddy Sunarto looks at the COP29 conference, where leaders are discussing carbon-credit trading rules, a crypto levy, and a 10x in climate finance.
Emerging competing takeover offers for SelfWealth and E&P Financial’s pending privatisation reflect the poor track record of the listed brokers.
Mining doyen Barry FitzGerald looks at the potential for a turnaround at Aeris Resources with the copper market preparing for liftoff.
Vale has taken a keen interest in unheralded junior Cyclone Metals, entering a non-binding MoU over its Iron Bear iron ore project in Canada.
The ASX rose on Friday, with NoviqTech almost tripling on blockchain funding. MinRes, however, dipped again and US Fed boss Jerome Powell cooled rate-cut hopes.
Morgans healthcare analyst Scott Power notes that while the S&P/ASX 200 Health Care index is down 1.4% over the past five days, some firms have soared on positive news.
Typically a safe haven asset, gold could recover its trajectory in a Trump 2.0 presidency according to the World Gold Council.
The ASX is on the rise on Friday, despite the Fed boss’s hawkish stance. Also, MinRes has admitted a slip-up and Cyclone Metals has surged after a deal with Vale.
Good morning! Here’s everything you need to know before the ASX opens today.
Falling critical minerals prices have hit 50 of Australia’s largest miners, delivering a 37 per cent collective hit to their earnings in 2024.
The Aussie ETF industry has reached $233 billion with international stocks leading inflows, while Betashares launched an ethical Aussie bond ETF.
Chinese car maker BYD appears set to overtake US giant Ford in annual EV shipments. That’s largely because of demand for hybrids – which are also booming in Australia.
WA-based gas stocks have every reason to cheer Asian demand growth – and a recent state government decision. Meanwhile, others are getting busy in SA and Queensland.
Variscan Mines has reawakened after returning with underground drilling at a zinc mine in Spain ignored for almost 100 years.
Collette Capital’s Steve Collette says interest is returning in semiconductor stock Archer Materials, which is eyeing new resistance levels after a mid-year slump.
ASX stock Actinogen reports its advanced – and novel – Alzheimer’s disease trial is recruiting strongly, with first results expected by mid next year.
Stockhead TV brings you today’s Break it Down, detailing the initial inferred resource estimate from Far East Gold’s Indonesian Idenburg project.
Mt Isa’s underground copper mines are set to close in 2025, but Queensland explorers are looking to step into the breach.
These ASX health stocks, which are cashing in on Chinese enthusiasm for Australian products, found a massive audience at the world’s largest trade show.
Guy Le Page goes into post-Trump metals markets before looking at Capricorn-adjacent Peregrine Gold as his stock of the week.
Barring unforeseen rivals, Imricor will have a 100 per cent share of the MRI-guided cardiac catheter ablation market, writes Tim Boreham.
The Trump administration is expected to liberalise research into psychedelic-assisted therapies – and Emyria investors have taken note. Read more in our health wrap.
BMG Resources and Metal Hawk are preparing to drill down on gold projects in WA’s northern Goldfields.
Western Gold Resources’ CEO Cullum Winn joins Barry FitzGerald on the Explorers Podcast to talk about the company’s Gold Duke project in the Goldfields region of Western Australia.
The ASX dropped on Wednesday as banks and miners slid, with MinRes falling hard. And Trump has tapped Musk to lead a new DOGE department. Yep, you read that right.
Bank stocks have fallen on the ASX on Wednesday, with gold dipping below $US2600. The news has been better for Nvidia, as it hit record highs.
Host Fraser Palamara explains the major autism and ADHD study BlinkLab is getting involved in with Melbourne’s Monash University.
A mix of good luck and good planning is set to pay off for Botanix – with its FDA-approved drug to treat excessive sweating in the process of a ‘soft’ US launch.
These two ASX copper-gold stocks have attracted affection from brokers, with one given a price target more than double its current level.
There is no shortage of ASX healthcare companies with upcoming catalysts – a focal point for investors. Here are five ready to make strong moves.
CBA’s mining guru says iron ore prices may sink below $US100/t, with China perhaps waiting for clear signals about US tariff intentions before boosting stimulus.
ASX 200 drops as gold, iron ore, and energy stocks struggle. Paladin tumbles but Bitcoin… it’s had a bit of big day.
The local bourse has fallen again as mining and energy stocks dip, with Paladin Energy cutting guidance and shares plunging over 20%.
WA’s state government has signed a funding agreement that will usher in construction work on a new graphite plant in Collie.
Bitcoin keeps hitting new highs, with investors eyeing $100K by December amid nation-state buying rumours and US reserve talks.
LTR Pharma and EZZ Life Sciences have been promoted to a flagship global microcaps index, at the expense of Opthea. Read more in our health wrap.
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the new share placement to advance gold projects from Native Mineral Resources.
A (nearly) trillion-dollar market beckons for Suvo as it revolutionises cement production – which ‘accounts for more emissions than the entire global car fleet’.
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the new diabetic foot infection treatment trial from Recce Pharmaceuticals.
Donald Trump’s election adds further risks to elevated share valuations and investors might want to think of protection.
Gold is crashing through record highs, and that has juniors itching to get into production and capitalise when the price is right.
ASX mining stocks have fallen on Monday, as Resolute Mining dropped following its CEO’s Mali detention, and Bitcoin rocketed to an all-time high, past $US81k.
Local markets lifted by news about US rate cuts, uranium stocks soared on supply cut.
Mining and China-sensitive stocks have dipped on Monday, with Resolute Mining plunging after its CEO’s detention in Mali.
A fintech junior and a copper hunter are standouts in Monday morning trade, while more broadly, miners have slumped.
Tony looks at Talisman Mining, who has Kerry Harmanis on board and is using its MinRes royalties to fund some exciting exploration plays.
US President-elect Trump’s promised tariffs could drive up prices and inflation – bad news for Australia – but these ASX stocks may benefit from his policies.
Gold prices are at super levels, and veteran resources scribe Barry FitzGerald is intrigued by Tasmanian explorer Flynn Gold.
While Cannindah’s share price has more than halved this year, the Queensland junior has quietly been ticking off milestones, says Kristie Batten.
Copper prices have tumbled but supply remains tight in a world increasingly hungry for the red metal. These ASX developers are working hard to address the shortfall.
A new explorer plans to list on the bourse, then make itself at home in NSW’s prolific Lachlan Fold Belt, with some of Australia’s top gold mines for neighbours.
Equinox soars on record 70% antimony grades at Alturas, NMR buys two QLD gold assets for $18.9m and Pantera well tests Smackover.
Albemarle cuts back and Arcadium reports skinny earnings as lithium producers keep trying to ride out the storm of low prices.
It’s good news all round for investors wanting to promote biodiversity, with a new index, a strategy for nature and the exciting ‘Nature Positive Matters’ initiative.
The ASX rallied in Friday action on tech gains, with CBA hitting a record and Neuren soaring. Meanwhile, Asian markets rose on China stimulus hopes.
The ASX rose on Friday morning, thanks to Wall Street’s gains and China stimulus hopes. The bourse was led by gold miners, while Block dropped despite profit growth.
Stockhead TV brings you today’s Break it Down, detailing the first European production of lithium hydroxide by Vulcan Energy Resources.
Original URL: https://www.news.com.au/finance/business/stockhead/news/page/23